EGFR status assessment using reflex testing targeted next-generation sequencing for resected non-squamous non-small cell lung cancer
Virchows Archiv · 2025
DOI: 10.1007/s00428-024-04010-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Virchows Archiv, 2025. Verfasst von Samantha Goffinet und 20 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d'Azur, CHU Nice, FHU OncoAge, IHU RespirERA, Nice, France. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, High-Throughput Nucleotide Sequencing, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Agence Nationale de la Recherche.
Abstract (Originalsprache)
EGFR status assessment is mandatory for adjuvant decision-making of resected stage IB-IIIA non-squamous non-small cell lung cancer (NS-NSCLC). It is questionable whether single-gene RT-PCR versus next-generation sequencing (NGS) should be used for this evaluation. Moreover, co-occurring mutations have an impact on tumor behavior and may influence future therapeutic decision-making. We aimed to describe the clinico-pathological and molecular features, as well as the prognostic factors of resected EGFR-mutant NS-NSCLC evaluated with reflex NGS and RT-PCR, so as to compare the results of the two methods. We retrospectively included and collected data from patients with resected EGFR-mutant NS-NSCLC diagnosed in our institution between 2005 and 2024. Additional cases from another center were included. Tumors were analyzed using targeted NGS and RT-PCR. A total of 153 patients were selected. The median follow-up after surgery was 22 months. The positive percent agreement of RT-PCR compared to NGS for the detection of an EGFR mutation was 88%. Common single EGFR mutations (L858R/del19) were observed in 117/153 (77%) cases; 22/153 (14%) and 14/153 (9%) cases had uncommon single and compound EGFR mutations, respectively. 63/153 (41%) patients had a co-occurring mutation, including a TP53 mutation in 43/63 (68%) co-mutated patients. EGFR/TP53-mutant tumors were associated with positive PD-L1 expression compared to EGFR-mutant/TP53-wild-type tumors (62% vs 39%; p = 0.006). Shorter median event-free survival (EFS) in patients with an EGFR exon 18 mutation and those with TP53 exon 7 co-mutation was recorded. The EGFR status should be systematically evaluated using targeted NGS reflex testing for resected NS-NSCLC since future therapeutic decision-making could soon consider integrating the presence of co-occurring mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d'Azur, CHU Nice, FHU OncoAge, IHU RespirERA, Nice, France.
- Université Côte d'Azur, CNRS, INSERM, IRCAN, FHU OncoAge, Nice, France.
- Hospital-Integrated Biobank BB-0033-00025, Université Côte d'Azur, CHU Nice, FHU OncoAge, Nice, France.
- Department of Thoracic/Head & Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
- Department of Cardiac, Thoracic,Vascular Science and Public Health, University of Padova, Padua, Italy.
- Department of Oncology, Princess Grace Hospital, Monaco, Monaco.
Förderung
- Agence Nationale de la Recherche
Zitieren
APA
Goffinet, S., Bontoux, C., Heeke, S., Pezzuto, F., Ilié, M., Long-Mira, E., Lassalle, S., Bordone, O., Lespinet, V., Allégra, M., Tanga, V., Bonnetaud, C., Garnier, G., Benzaquen, J., Cohen, C., Ferrari, V., Marquette, C., Berthet, J. P., Calabrese, F., …, & Hofman, V. (2025). EGFR status assessment using reflex testing targeted next-generation sequencing for resected non-squamous non-small cell lung cancer. Virchows Archiv. https://doi.org/10.1007/s00428-024-04010-4
Vancouver
Goffinet S, Bontoux C, Heeke S, Pezzuto F, Ilié M, Long-Mira E, et al. EGFR status assessment using reflex testing targeted next-generation sequencing for resected non-squamous non-small cell lung cancer. Virchows Archiv. 2025. doi:10.1007/s00428-024-04010-4
BibTeX
@article{Goffinet2025,
author = {Goffinet, Samantha and Bontoux, Christophe and Heeke, Simon and Pezzuto, Federica and Ilié, Marius and Long-Mira, Elodie and Lassalle, Sandra and Bordone, Olivier and Lespinet, Virginie and Allégra, Maryline and Tanga, Virginie and Bonnetaud, Christelle and Garnier, Georges and Benzaquen, Jonathan and Cohen, Charlotte and Ferrari, Victoria and Marquette, Charles and Berthet, Jean Philippe and Calabrese, Fiorella and Hofman, Paul and Hofman, Véronique},
title = {EGFR status assessment using reflex testing targeted next-generation sequencing for resected non-squamous non-small cell lung cancer},
journal = {Virchows Archiv},
year = {2025},
doi = {10.1007/s00428-024-04010-4}
}
EUVIMED